Healthcare provider profile · identity verified

Jeffrey D Henry, M.D.

Family Practice · HAYS, KS · NPI 1154397743

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	465	108
Levothyroxine Sodium	Levothyroxine Sodium	400	78
Losartan Potassium	Losartan Potassium	264	49
Amlodipine Besylate	Amlodipine Besylate	235	53
Omeprazole	Omeprazole	227	57
Lisinopril	Lisinopril	224	53
Rosuvastatin Calcium	Rosuvastatin Calcium	177	49
Gabapentin	Gabapentin	173	30
Pantoprazole Sodium	Pantoprazole Sodium	161	37
Tamsulosin Hcl	Tamsulosin Hcl	132	25
Simvastatin	Simvastatin	131	32
Hydrochlorothiazide	Hydrochlorothiazide	129	32
Metformin Hcl	Metformin Hcl	126	23
Sertraline Hcl	Sertraline Hcl	125	16
Metformin Hcl Er	Metformin Hcl	123	34
Tramadol Hcl	Tramadol Hcl	118	19
Furosemide	Furosemide	116	23
Allopurinol	Allopurinol	104	21
Potassium Chloride	Potassium Chloride	92	15
Eliquis	Apixaban	91	12
Famotidine	Famotidine	90	22
Fluticasone Propionate	Fluticasone Propionate	83	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	19
Metoprolol Tartrate	Metoprolol Tartrate	82	21
Metoprolol Succinate	Metoprolol Succinate	79	20
Buspirone Hcl	Buspirone Hcl	77	12
Citalopram Hbr	Citalopram Hydrobromide	68	12
Trazodone Hcl	Trazodone Hcl	66	11
Clopidogrel	Clopidogrel Bisulfate	64	suppressed
Duloxetine Hcl	Duloxetine Hcl	63	13
Venlafaxine Hcl Er	Venlafaxine Hcl	62	suppressed
Glipizide	Glipizide	61	14
Donepezil Hcl	Donepezil Hcl	60	suppressed
Meloxicam	Meloxicam	60	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	19
Spironolactone	Spironolactone	56	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Alprazolam	Alprazolam	52	suppressed
Memantine Hcl	Memantine Hcl	52	suppressed
Ozempic	Semaglutide	52	11
Albuterol Sulfate Hfa	Albuterol Sulfate	49	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	12
Hydroxyzine Hcl	Hydroxyzine Hcl	44	suppressed
Atenolol	Atenolol	43	suppressed
Prednisone	Prednisone	43	26
Carvedilol	Carvedilol	42	11
Jardiance	Empagliflozin	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Myrbetriq	Mirabegron	36	suppressed
Memantine Hcl Er	Memantine Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Mirtazapine	Mirtazapine	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Tresiba Flextouch U-200	Insulin Degludec	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Finasteride	Finasteride	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Azithromycin	Azithromycin	22	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Ramipril	Ramipril	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Ezetimibe	Ezetimibe	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Naratriptan Hcl	Naratriptan Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Chlordiazepoxide-Clidinium	Chlordiazepoxide/Clidinium Br	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error